Jeremy Shefner
Neurology · Phoenix, AZNPI 1184682882
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $140,664 of the $163,046 with a category attached, or 86.3%. It is spread thinly across 25 manufacturers, the largest accounting for just 16.8%. Among neurology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $1582.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$27K
- Sarepta Therapeutics, Inc.$25K
- Apellis Pharmaceuticals, Inc.$16K
- Tanabe Pharma America, Inc.$14K
- Sanofi$13K
- Sanofi US Services Inc.$10K
- plus $58K from 19 others
Across 52 payments — averaging $55,424 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tanabe Pharma America, Inc.$1.9M
- Biogen$760K
- Mitsubishi Tanabe Pharma Holdings America, Inc.$145K
- Sanofi$33K
- Ionis Pharmaceuticals, Inc.$15K
- Biohaven Pharmaceutical Holding Company Ltd.$1K
What the payments were for
- Consulting fees$140,66486%
- Speaking & faculty fees$14,3359%
- Travel & lodging$6,6564%
- Food & beverage$1,3911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 18 | $27,338 |
| Sarepta Therapeutics, Inc. | 1 | $25,000 |
| Apellis Pharmaceuticals, Inc. | 6 | $16,126 |
| Tanabe Pharma America, Inc. | 12 | $13,859 |
| Sanofi | 8 | $13,497 |
| Sanofi US Services Inc. | 1 | $9,696 |
| Amylyx Pharmaceuticals, Inc. | 6 | $9,043 |
| Argenx US, Inc. | 4 | $7,062 |
| Mitsubishi Tanabe Pharma Holdings America, Inc. | 3 | $6,325 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 10 | $6,249 |
| Biogen | 3 | $5,916 |
| Sanofi-aventis U.S. LLC | 3 | $5,734 |
| Janssen Global Services, LLC | 1 | $3,100 |
| E.r. Squibb & Sons, L.L.C. | 1 | $2,500 |
| UCB SA | 1 | $2,200 |
| GSK | 2 | $2,017 |
| Teva Pharmaceuticals USA, Inc. | 1 | $1,890 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 5 | $1,695 |
| PTC Therapeutics, Inc. | 2 | $1,028 |
| Biomarin Pharmaceutical Inc. | 1 | $1,000 |
| Neurocrine Biosciences, Inc. | 10 | $540 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $450 |
| Corcept Therapeutics | 1 | $400 |
| EMD Serono, Inc. | 1 | $330 |
| EDW Pharma, Inc. | 1 | $51 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$163,046 in reported general payments places this provider in the 90th percentile of 388 neurology providers in Arizona.
Other neurology in Phoenix
- Barry HendinPhoenix$2.3M
- Maria OspinaPhoenix$2.1M
- Suraj MuleyPhoenix$1.7M
- Eric ErossPhoenix$778K
- Steve ChungPhoenix$685K
- Marwan SabbaghPhoenix$603K
- Kerry KnievelPhoenix$509K
- Lori TravisPhoenix$406K
- Jeffrey GittPhoenix$275K
- Todd SchwedtPhoenix$273K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.